生物相容的非线性PEG核心外纳米凝具有高负载能力,卓越的稳定性和可控释放的黄素
Jing Shen1,2, Jiangtao Zhang1, Weitai Wu3
1Department of Chemistry of The College of Staten Island and PhD Program in Chemistry of Graduate Center, The City University of New York, 2800 Victory Boulevard, Staten Island, NY 10314, USA.
Gels (Basel, Switzerland)
|September 27, 2023
概括
研究人员开发了生物相容的聚乙烯)@非线性聚乙烯甘醇) (PVAS@PEG) 纳米凝,以改善黄的输送. 这些纳米凝增强了黄素.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 黄素对糖尿病和癌症具有治疗潜力,但由于水溶性较低和快速降解,其生物利用性较差.
- 有效的输送系统对于克服黄素的局限性和利用其药用特性至关重要.
研究的目的:
- 为了工程生物相容的聚乙烯)@非线性聚乙烯糖醇) (PVAS@PEG) 核心外纳米凝增强黄素的交付.
- 研究PEG外厚度对纳米凝特性和黄素释放动力学的影响.
主要方法:
- 合成具有不同PEG外厚度的PVAS@PEG核心外纳米凝.
- 纳米凝形态,尺寸和黄素载荷能力的表征.
- 评估黄素的稳定性,体外释放特征,细胞吸收和细胞毒性.
主要成果:
- 能够控制尺寸和外厚度的单分散球形PVAS@PEG纳米凝成功制备.
- 优化的纳米凝实现了高黄素负载能力38.0重量%,稳定了黄素降解,并证明了热响应释放.
- 纳米凝在B16F10和HL-7702细胞中表现出有效的细胞吸收和可以忽略的细胞毒性.
结论:
- PVAS@PEG核心外纳米凝代表了改善黄素生物可用性和治疗功效的有希望的平台.
- 这些纳米凝的可调性性质允许控制药物加载和释放,为高效的药物输送应用提供了潜力.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...


